Pasar al contenido principal

ESTRATEGIAS DE DIRECCIONAMIENTO DE NANOSISTEMAS MAGNETICOS MULTIFUNCIONALES PARA TERAPIA E IMAGEN IN VIVO DE GLIOMAS DE ALTO GRADO: VALIDACION EN MODELOS PDOX

PID2020-118448RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD, M.P.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron–gold nanoflowers: A promising tool for multimodal imaging and hyperthermia therapy

  • Christou, Evangelia
  • Pearson, John R.
  • Beltrán, Ana M.
  • Fernández-Afonso, Yilian
  • Gutiérrez, Lucía
  • Fuente, Jesús M. de la
  • Gámez, Francisco
  • García-Martín, María L.
  • Caro, Carlos
This article belongs to the Special Issue Recent Advances in Metallic Nanoparticles as Theranostics Platforms., The development of nanoplatforms prepared to perform both multimodal imaging and combined therapies in a single entity is a fast-growing field. These systems are able to improve diagnostic accuracy and therapy success. Multicomponent Nanoparticles (MCNPs), composed of iron oxide and gold, offer new opportunities for Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) diagnosis, as well as combined therapies based on Magnetic Hyperthermia (MH) and Photothermal Therapy (PT). In this work, we describe a new seed-assisted method for the synthesis of Au@Fe Nanoparticles (NPs) with a flower-like structure. For biomedical purposes, Au@Fe NPs were functionalized with a PEGylated ligand, leading to high colloidal stability. Moreover, the as-obtained Au@Fe-PEG NPs exhibited excellent features as both MRI and CT Contrast Agents (CAs), with high r2 relaxivity (60.5 mM−1⋅s−1) and X-ray attenuation properties (8.8 HU mM−1⋅HU). In addition, these nanoflowers presented considerable energy-to-heat conversion under both Alternating Magnetic Fields (AMFs) (∆T ≈ 2.5 °C) and Near-Infrared (NIR) light (∆T ≈ 17 °C). Finally, Au@Fe-PEG NPs exhibited very low cytotoxicity, confirming their potential for theranostics applications, Financial support was provided the Ministerio de Economía, Industria y Competitividad (CTQ2017-86655-R), Ministerio de Ciencia e Innovación (PID2020-118448RB-C21, PID2020-113108RB-I00 (funded by MCIN/AEI/10.13039/50110001103), and PGC2018-096016-B-I00, the Fondo Social de la DGA (grupos DGA)), and by the Regional Ministry of Health of Andalusia (OH-0026-2018 and PAIDI 2020. P20_00727)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimization of iron oxide nanoparticles for MRI-guided magnetic hyperthermia tumor therapy: reassessing the role of shape in their magnetocaloric effect

  • Páez-Muñoz, Jose María
  • Gámez, Francisco
  • Fernández-Afonso, Yilian
  • Gallardo, Roberto
  • Pernía Leal, Manuel
  • Gutiérrez, Lucía
  • Fuente, Jesús M. de la
  • Caro, Carlos
  • García-Martín, María L.
Superparamagnetic iron oxide nanoparticles have hogged the limelight in different fields of nanotechnology. Surprisingly, notwithstanding the prominent role played as agents in magnetic hyperthermia treatments, the effects of nanoparticle size and shape on the magnetic hyperthermia performance have not been entirely elucidated yet. Here, spherical or cubical magnetic nanoparticles synthesized by a thermal decomposition method with the same magnetic and hyperthermia properties are evaluated. Interestingly, spherical nanoparticles displayed significantly higher magnetic relaxivity than cubic nanoparticles; however, comparable differences were not observed in specific absorption rate (SAR), pointing out the need for additional research to better understand the connection between these two parameters. Additionally, the as-synthetized spherical nanoparticles showed negligible cytotoxicity and, therefore, were tested in vivo in tumor-bearing mice. Following intratumoral administration of these spherical nanoparticles and a single exposure to alternating magnetic fields (AMF) closely mimicking clinical conditions, a significant delay in tumor growth was observed. Although further in vivo experiments are warranted to optimize the magnetic hyperthermia conditions, our findings support the great potential of these nanoparticles as magnetic hyperthermia mediators for tumor therapy., C. Caro thanks the Regional Ministry of Health and Families for his senior postdoctoral grant (RH-0040-2021). Financial support was provided by the Spanish Ministry of Economy, Industry and Competitiveness (CTQ2017-86655-R), the Spanish Ministry of Science and Innovation (PID2020-118448RB-C21, PID2020-118448RB-C22 and PID2022-136919NA-C33) (funded by MCIN/AEI/10.13039/50110001103), the Regional Ministry of Health of Andalusia (OH-0026-2018), the Regional Ministry of Economic Transformation, Industry, Knowledge and Universities of Andalusia (PAIDI 2020. P20_00727) and European FEDER funds and the Junta de Andalucía (P18-RT-1663)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based trimodal probes for near-infrared luminescent bioimaging, high-field magnetic resonance imaging, and X-ray computed tomography

  • Gómez-González, Elisabet
  • González-Mancebo, Daniel
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We have developed a trimodal bioimaging probe for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography using Dy3+ as the paramagnetic component and Nd3+ as the luminescent cation, both of them incorporated in a vanadate matrix. Among different essayed architectures (single phase and core–shell nanoparticles) the one showing the best luminescent properties is that consisting of uniform DyVO4 nanoparticles coated with a first uniform layer of LaVO4 and a second layer of Nd3+-doped LaVO4. The magnetic relaxivity (r2) at high field (9.4 T) of these nanoparticles was among the highest values ever reported for this kind of probes and their X-ray attenuation properties, due to the presence of lanthanide cations, were also better than those of a commercial contrast agent (iohexol) commonly used for X-ray computed tomography. In addition, they were chemically stable in a physiological medium in which they could be easily dispersed owing to their one-pot functionalization with polyacrylic acid, and, finally, they were non-toxic for human fibroblast cells. Such a probe is, therefore, an excellent multimodal contrast agent for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography., Financial support by Junta de Andalucía (P20_00182) is acknowledged. This publication is part of the I + D + I Grants RTI2018-094426-B-I00, PID2021-122328OB-I00, and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography

  • González-Mancebo, Daniel
  • Becerro, Ana Isabel
  • Caro, Carlos
  • Gómez-González, Elisabet
  • García-Martín, María L.
  • Ocaña, Manuel
File List: Fig 1 F1b: Size histogram of Ba40Dy60 NPs F1c: EDX spectrum of Ba40Dy60 NPs F1e: Size histogram of Ba51Dy49 NPs F1f: F1c: EDX spectrum of Ba51Dy49 NPs Fig 2 F2: Experimental XRD patterns of Ba40Dy60 and Ba51Dy49 samples Fig 3 F3b: XRD patterns of the precipitates obtained in the conditions used for the synthesis of Ba51Dy49 NPs but using different aging times F3c: Unit cell parameters and Ba/(Ba+Dy) ratio of the precipitates versus aging time Fig 4 F4a: DLS intensity curves of the Ba51Dy49 NPs suspended in water after different periods of time at rest F4b: FTIR spectrum of the Ba51Dy49 NPs Fig 5 F5g: Total number of cells per well after exposure to increasing concentration of NPs F5h: Percentage of dead cells after exposure to increasing concentration of Ba51Dy49 NPs. F5i: MTT assay of cells exposed to increasing concentration of Ba51Dy49 NPs Fig 6 F6a: 1/T2 values obtained in aqueous suspensions of Ba51Dy49 NPs at 9.4 T and 1.44 T versus Dy concentration of the suspensions Fig 7 F7b: X-ray attenuation at 80 kVp, in Hounsfield Units (HU), of aqueous suspensions containing Ba51Dy49 NPs and Iohexol, versus suspension concentration. F7c: X-ray attenuation, in HU, of aqueous suspensions containing 20.0 mg·mL-1 of Ba51Dy49 and DyF3 NPs, versus working voltage, Bimodal medical imaging based on Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is a well-known strategy to increase diagnostic accuracy. The most recent advances in MRI and CT instrumentation are related to the use of ultrahigh magnetic fields (UHF-MRI) and different working voltages (spectral CT), respectively. Such advances require the parallel development of bimodal contrast agents (CAs) that are efficient under the new instrumental conditions. In this work, we have synthesized, through a precipitation reaction from a glycerol solution of the precursors, uniform barium dysprosium fluoride nanospheres with cubic fluorite structure, whose size was found to depend on the Ba/(Ba+Dy) ratio of the starting solution. Moreover, irrespective of the starting Ba/(Ba+Dy) ratio, the experimental Ba/(Ba+Dy) values were always lower than those used in the starting solutions. This result was assigned to a lower precipitation kinetics of barium fluoride compared to dysprosium fluoride, as inferred from the detailed analysis of the effect of reaction time on the chemical composition of the precipitates. A sample composed of 34 nm nanospheres with a Ba0.51Dy0.49F2.49 stoichiometry, showed a transversal relaxivity (r2) value of 147.11 mM-1·s-1 at 9.4 T and gave a high negative contrast in the phantom image. Likewise, it produced high X-ray attenuation in a large range of working voltages (from 80 KVp to 140 KVp), which can be attributed to the presence of different K-edge values, high Z elements (Ba and Dy) in the nanospheres. Finally, these nanospheres showed negligible cytotoxicity for different biocompatibility tests. Taken together, these results show that the reported nanoparticles (NPs) are excellent candidates as UHF MRI/Spectral CT bimodal imaging CAs., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography

  • González-Mancebo, Daniel
  • Becerro, Ana Isabel
  • Caro, Carlos
  • Gómez-González, Elisabet
  • García-Martín, María Luisa.
  • Ocaña, Manuel
Chemicals and CAS Registry Numbers barium 7440-39-3 dysprosium 7429-91-6 fluoride 16984-48-8, Bimodal medical imaging based on magnetic resonance imaging (MRI) and computed tomography (CT) is a well-known strategy to increase the diagnostic accuracy. The most recent advances in MRI and CT instrumentation are related to the use of ultra-high magnetic fields (UHF-MRI) and different working voltages (spectral CT), respectively. Such advances require the parallel development of bimodal contrast agents (CAs) that are efficient under new instrumental conditions. In this work, we have synthesized, through a precipitation reaction from a glycerol solution of the precursors, uniform barium dysprosium fluoride nanospheres with a cubic fluorite structure, whose size was found to depend on the Ba/(Ba + Dy) ratio of the starting solution. Moreover, irrespective of the starting Ba/(Ba + Dy) ratio, the experimental Ba/(Ba + Dy) values were always lower than those used in the starting solutions. This result was assigned to lower precipitation kinetics of barium fluoride compared to dysprosium fluoride, as inferred from the detailed analysis of the effect of reaction time on the chemical composition of the precipitates. A sample composed of 34 nm nanospheres with a Ba0.51Dy0.49F2.49 stoichiometry showed a transversal relaxivity (r2) value of 147.11 mM-1·s-1 at 9.4 T and gave a high negative contrast in the phantom image. Likewise, it produced high X-ray attenuation in a large range of working voltages (from 80 to 140 kVp), which can be attributed to the presence of different K-edge values and high Z elements (Ba and Dy) in the nanospheres. Finally, these nanospheres showed negligible cytotoxicity for different biocompatibility tests. Taken together, these results show that the reported nanoparticles are excellent candidates for UHF-MRI/spectral CT bimodal imaging CAs., This publication is part of the I + D + I grants PID2021-122328OB-I00 and PID2020-118448RB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, cofinanced by EU FEDER funds. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Multimodal lanthanide vanadate-based nanoparticles for T1 -T2 MRI and NIR luminescent imaging

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., F2 F2b_ FTIR spectrum of single-phase nanoparticles. F2c_ TGA curve of the single-phase nanoparticles. F2d_XRD pattern of the single-phase nanoparticles_ black. F2d_GdVO4 PDF_red. F2d_DyVO4 PDF_navy. F4 F4b_ XRD pattern of the core-shell nanoparticles_ black F4b_GdVO4 PDF_red. F4b_DyVO4 PDF_navy. F4c: FTIR spectrum of the core-shell nanoparticles. F4d: TGA curve of the core-shell nanoparticles. F6 F6_top_blue: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_top_red: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F6_bottom_blue: The transverse (1/T2) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_bottom_red: The transverse (1/T2) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F7 F7b_XRD pattern of the Dy@Y@Nd:Gd sample_black. F7b_DyVO4 PDF_grey. F7b_GdVO4 PDF_red F7b_YVO4 PDF_blue F7c_FTIR spectrum of the Dy@Y@Nd:Gd sample. F7d_TGA curve of the Dy@Y@Nd:Gd sample. F9 F9_blue: Relaxation rates (1/T1) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F9_red: Relaxation rates (1/T2) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F10 F10_top: Excitation spectrum for the Dy@Y@Nd:Gd sample. F10_ bottom: Emission spectrum for the Dy@Y@Nd:Gd sample. F11 F11_grey: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in water. F11_red: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in MES medium. F11_blue: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in PBS medium. F11_green: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in saline medium. F12 F12_Histogram_1 day: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during one day. F12_Histogram_21 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 21 days. F12_Histogram_35 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 35 days. F13 F13d_Analysis of the total number of cells per well exposed to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13e_Dead cell percentage to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13f_Mitochondrial activity of the cells to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. FS1 FS1a_Size distribution histogram of the single-phase nanoparticles containing Gd and Dy as a solid solution. FS1b_Size distribution histogram of the DyVO4 nanoparticles coated with a GdVO4 shell. FS1c_Size distribution histogram of the DyVO4 nanoparticles coated with a first YVO4 shell and with a second shell consisting of GdVO4 doped with Nd3+. FS2 FS2b_Size distribution histogram for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2c_ DLS curve in water suspension for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_XRD pattern for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_DyVO4_PDF FS2e_FTIR spectrum for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2f_TGA curve for the DyVO4 nanoparticles functionalized with PAA used as cores., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., Elisabet Gómez-González, Carlos Caro, Nuria O. Núñez, Daniel González-Mancebo, Jesús D. Urbano-Gámez, María L. García-Martín and Manuel Ocaña. Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging. Journal of Materials Chemistry B [In press], Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based nanoparticles as multimodal T1 -T2 MRI contrast agent and NIR luminescent imaging probe

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your Future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protein corona as the key factor governing the in vivo fate of magnetic nanoparticles

  • Avasthi, Ashish
  • Fernández-Afonso, Yilian
  • Gutiérrez, Lucía
  • Fuente, Jesús M. de la
  • Pernía Leal, Manuel
  • Caro, Carlos
  • García-Martín, María L.
The data that support the findings of this study are available from the corresponding authors upon reasonable request., Advancements in the field of nanotechnology have opened a myriad of avenues for diverse applications. One such avenue is the role of nanoparticles (NPs) in the healthcare sector, whether it is drug targeting, drug delivery, or imaging, offering unprecedented prospects for improving targeted interventions along with minimal toxicity. Meanwhile, the intricate interplay between the characteristics of NPs and the ensuing biological cross-talk has engendered profound interest among scientists. Amidst the determinants shaping the behavior of NPs within the biological milieu, the biodistribution and pharmacokinetics of the NPs stand as pivotal factors intricately intertwined with their core size, hydrodynamic diameter (HD), coating ligands, as well as the proteins they interact with, forming the protein corona. This article compiles and analyzes the data to decipher the factors determining the fate of NPs in vivo. For this purpose, two IONPs with differing core sizes (≈4 nm and ≈8 nm) but coated with the same gallol-PEG ligand (GA-PEG3000-OH) and possessing very similar HDs (≈35 nm) as well as relaxivity (≈100 mM−1 s−1) were selected. Following physicochemical characterization, both protein coronas were thoroughly analyzed, revealing differences in both the composition and the relative abundance. Later, after determining the negligible cytotoxicity of both NPs, they were intravenously injected into Balb/c mice to evaluate their in vivo biodistribution and pharmacokinetics using MRI. Additionally, biodistribution was further investigated ex vivo by quantitative magnetic analysis of blood and tissues, alongside histological evaluation. Our results evidenced that the protein corona, rather than core size or hydrodynamic diameter, is the determining factor governing the in vivo fate of magnetic NPs., Financial support was provided by grant P20_00727/PAIDI2020 (to M. L. G. M.), funded by the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía, Spain; grants PID2020-118448RBC21 (to M. L. G. M.) and PID2020-118448RBC22 (to M. P. L.), funded by MCIN/AEI/10.13039/501100011033; grant CNS2023-144321 (to L. G.) funded by MICIU/AEI/10.13039/501100011033 and NextGenerationEU/PRTR. C. Caro acknowledges the support of his senior postdoctoral grant RH-0040-2021, funded by the Consejería de Salud y Familias, Junta de Andalucía. This work has also been supported by CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB16/01/00263 to J. M. F.). J. M. F also acknowledges support from Gobierno de Aragón for funding the Bionanosurf (E15_20R) research group., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset -Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Files List: Figure 1 F1b_Particle size histogram (b) of the synthesized nanoparticles Figure 2 F2a_blue XRD pattern of the synthesized nanoparticles F2a_red ticks corresponding to the tetragonal NaDy(WO4)2 (25-829 PDF file). F2b_FTIR spectrum of the tetragonal NaDy(WO4)2 nanoparticles F2c_TGA curve of the tetragonal NaDy(WO4)2 nanoparticles. Figure 3 F3_MES_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 0 h. F3_MES_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 24 h. F3_MES_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 48 h. F3_MES_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 72 h. F3_Saline_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 0 h. F3_Saline_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 24 h. F3_Saline_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 48 h. F3_Saline_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 72 h. F3_Water_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 0 h. F3_Water_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 24 h. F3_Water_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 48 h. F3_Water_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 72 h. Figure 5 F5c_Percentage of dead cells obtained from live-dead analysis F5d_black_Negative and positive control for live-dead analysis F5d_cyan_total number of cells per well obtained from live-dead analysis Figure 6 F6_black_negative and positive control for MTT assay F6_cyan_Mitochondrial activity of cells exposed to increasing concentration of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles evaluated by MTT assay Figure 7 F7c_EDX spectrum taken from the region marked with a white square in Figure 7 (a). Figure 8 F8_left_Viability of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h F8_right_Brood size (right) of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h Figure 9 F9a_blue_Relaxation rates 1/T1 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9a_red_Relaxation rates 1/T1 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_blue_Relaxation rates 1/T2 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_red__Relaxation rates 1/T2 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles Figure 11 F11_green_X-ray attenuation values (in Hounsfield units, HU) of NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water F11_ red_X-ray attenuation values (in Hounsfield units, HU) of iohexol dispersed in water, Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020-118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Open Access Article. Published on 10 October 2025. Downloaded on 10/10/2025 10:25:41 AM. This article is licensed under a which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A multiparametric perspective on C6 and F98 cell lines in orthotopic rat models for glioblastoma research

  • Caro, Carlos
  • Arias-Ramos, Nuria
  • Urbano-Gámez, Jesús David
  • González-Alday, Raquel
  • López-Larrubia, Pilar
  • García-Martín, María L.
Glioblastoma remains a significant healthcare challenge due to its aggressiveness and poor prognosis, underscoring the urgent need for innovative approaches to tackle this disease. While there is a growing emphasis on the use of in vitro models for these developments, animal models continue to play a pivotal role, as they provide insights into the complex tumor microenvironment (TME) and host interactions that in vitro systems cannot fully replicate. However, selecting the appropriate animal model based on the research question is fundamental to ensure the reliability and translational potential of preclinical findings. Advanced neuroimaging techniques, particularly magnetic resonance imaging (MRI) and spectroscopy (MRS), offer unique advantages for the in vivo characterization of glioblastoma models. These techniques offer comprehensive morphological, functional, and metabolomic insights, enabling the evaluation of critical tumor features, such as vascular permeability, infiltrative capacity, or metabolism, among others. In this study, different glioblastoma models were generated by orthotopic implantation of two widely used glioblastoma cell lines, C6 and F98, in Fischer, Sprague Dawley, and Wistar rats and characterized by multiparametric MRI, MRS, along with histological analysis. Results revealed that the F98-Fischer model closely mimics human glioblastoma regarding vascular permeability, infiltrative growth, and key metabolic hallmarks. In contrast, the C6-Wistar model, while exhibiting similarities in permeability and metabolism, lacked invasive growth. Moreover, the two cell lines showed different responses to the host environment, with F98 consistently forming infiltrative tumors across rat strains, while C6 showed variability in tumor growth patterns, suggesting a greater dependence on the host microenvironment. These findings underscore the complex interplay between cell line genetics and host factors in defining tumor phenotype, emphasizing the importance of considering host-tumor interactions in glioblastoma research., Financial support was provided by grant CTQ2017-86655-R, funded by the Ministerio de Economia, Industria y Competitividad, Spain; Grant PID2020-118448RBC21, funded by MCIN/AEI/https://doi.org/10.13039/501100011033; and Grant PID2021-122528OB-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033/FEDER, UE. C. Caro acknowledges the support of his senior postdoctoral Grant RH-0040–2021, funded by the Consejería de Salud y Familias, Junta de Andalucía. Financial support was also provided through the contract granted to J.D. Urbano-Gámez, funded by the European Union—NextGenerationEU, and the Plan de Recuperación, Transformación y Resiliencia, through Grant Number MA/INV/0008/2022 by the Consejería de Empleo, Formación y Trabajo Autónomo of the Junta de Andalucía in the 2022 call of the Programa Investigo, Mecanismo de Recuperación y Resiliencia., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Iron–Gold Nanoflowers: A Promising Tool for Multimodal Imaging and Hyperthermia Therapy

  • Christou, E.
  • Pearson, J. R.
  • Beltrán, A. M.
  • Fernández-Afonso, Y.
  • Gutiérrez, L.
  • de la Fuente, J. M.
  • Gámez, F.
  • García-Martín, M. L.
  • Caro, C.
The development of nanoplatforms prepared to perform both multimodal imaging and combined therapies in a single entity is a fast-growing field. These systems are able to improve diagnostic accuracy and therapy success. Multicomponent Nanoparticles (MCNPs), composed of iron oxide and gold, offer new opportunities for Magnetic Resonance Imaging (MRI) and Computed To-mography (CT) diagnosis, as well as combined therapies based on Magnetic Hyperthermia (MH) and Photothermal Therapy (PT). In this work, we describe a new seed-assisted method for the synthesis of Au@Fe Nanoparticles (NPs) with a flower-like structure. For biomedical purposes, Au@Fe NPs were functionalized with a PEGylated ligand, leading to high colloidal stability. Moreover, the as-obtained Au@Fe-PEG NPs exhibited excellent features as both MRI and CT Contrast Agents (CAs), with high r2 relaxivity (60.5 mM-1·s-1 ) and X-ray attenuation properties (8.8 HU mM-1·HU). In addition, these nanoflowers presented considerable energy-to-heat conversion under both Alternating Magnetic Fields (AMFs) (¿T ˜ 2.5¿C) and Near-Infrared (NIR) light (¿T ˜ 17¿C). Finally, Au@Fe-PEG NPs exhibited very low cytotoxicity, confirming their potential for theranostics applications. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Light-to-Heat Conversion of Optically Trapped Hot Brownian Particles

  • Ortiz Rivero, Elisa
  • Orozco Barrera,Sergio
  • Chatterjee, Hirak
  • Caro, Carlos
  • González Gómez, Carlos David
  • García Martín, María Luisa
  • Haro González, Patricia
  • Rica, Raúl A.
  • Gámez Márquez, Francisco De Asis
Anisotropic hybrid nanostructures stand out as promising therapeutic agents in photothermal conversion-based treatments. Accordingly, understanding local heat generation mediated by light-to-heat conversion of absorbing multicomponent nanoparticles at the single-particle level has forthwith become a subject of broad and current interest. Nonetheless, evaluating reliable temperature profiles around a single trapped nanoparticle is challenging from all of the experimental, computational, and fundamental viewpoints. Committed to filling this gap, the heat generation of an anisotropic hybrid nanostructure is explored by means of two different experimental approaches from which the local temperature is measured in a direct or indirect way, all in the context of hot Brownian motion theory. The results were compared with analytical results supported by the numerical computation of the wavelength-dependent absorption efficiencies in the discrete dipole approximation for scattering calculations, which has been extended to inhomogeneous nanostructures. Overall, we provide a consistent and comprehensive view of the heat generation in optical traps of highly absorbing particles from the viewpoint of the hot Brownian motion theory.